137 results
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
9 May 24
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides
7:00am
trials and achieve regulatory milestones; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
8 May 24
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance
7:05am
operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory milestones; the nature, strategy
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory milestones; the nature, strategy and focus
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
trials and achieve regulatory milestones; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits
6-K
EX-99.1
bj4gcn
9 Nov 23
Current report (foreign)
8:00am
6-K
EX-99.2
zk4d judxa
9 Nov 23
Current report (foreign)
8:00am
F-3/A
hzv66chlm dic20
30 Oct 23
Shelf registration (foreign) (amended)
8:33am
F-3
EX-1.2
99vcp5
16 Oct 23
Shelf registration (foreign)
4:25pm
F-3
m3xjr1xz
16 Oct 23
Shelf registration (foreign)
4:25pm
F-3
EX-4.1
la2d5 0t7
16 Oct 23
Shelf registration (foreign)
4:25pm
6-K
EX-99.1
htod57h9q
14 Aug 23
Current report (foreign)
8:05am
6-K
EX-99.3
r9h70n nu2aj
14 Aug 23
Current report (foreign)
8:05am
8-K
EX-99.1
8ecb1q4kn0ud2x
5 Jun 23
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
7:00am
8-K
EX-99.1
d8e6140p6qqlhrcw
11 May 23
Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update
6:10am
8-K
EX-99.1
2q8r4hd5k28aw
14 Nov 22
Chemomab Announces Appointment of Matthew Frankel, MD, MBA
4:06pm